SCHEMBL4814770

SCHEMBL4814770

Cc1ccc2c(c1)OC1(CCC1)CC2N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.41
ATM Q13315 2/20 0.40
HTT P42858 1/20 0.40
LMNA P02545 1/20 0.38
RAF1 P04049 1/20 0.35
HTR2C P28335 2/20 0.31
HTR2B P41595 2/20 0.31
ALDH1A1 P00352 1/20 0.31
ALDH2 P05091 1/20 0.31
HTR1A P08908 1/20 0.31
SLC6A2 P23975 1/20 0.31
SIGMAR1 Q99720 1/20 0.31
MAOB P27338 4/20 0.31
MAOA P21397 2/20 0.31
KMT2A Q03164 1/20 0.31
NOS3 P29474 1/20 0.31
NOS1 P29475 1/20 0.31
NOS2 P35228 1/20 0.31
HTR2A P28223 1/20 0.31
HSD11B1 P28845 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL620214 0.98 KDM4E (0.40) KDM4EATMHTTLMNARAF1
Hydrochloric Acid SCHEMBL619668 0.87 KDM4E (0.43) KDM4EATMHTTLMNAHTR2C
SCHEMBL4350339 0.85 KDM4E (0.48) KDM4EATMHTTLMNAHTR2C
SCHEMBL618147 0.82 CA2 (0.34) KDM4ELMNARAF1HTR2BALDH1A1
SCHEMBL619207 0.82 TRPV1 (0.37) RAF1HTR2CHTR2BHTR2A
SCHEMBL617794 0.82 HTR2C (0.39) RAF1HTR2CHTR2BMAOBMAOA
SCHEMBL619734 0.81 MAPT (0.44) KDM4EHTTHTR2CHTR2BALDH1A1
SCHEMBL4361281 0.81 RAF1 (0.33) KDM4EATMHTTRAF1HSD11B1
SCHEMBL25660453 0.80 HTR2C (0.36) KDM4EHTR2CHTR2BALDH1A1ALDH2
SCHEMBL4355799 0.78 KDM4E (0.34) KDM4EATMHTTLMNARAF1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1931681-B1 SUBSTITUTED BENZOFUSED DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS SA (CH) 2012-11-14 EP disclosed
EP-1931681-A1 SUBSTITUTED BENZOFUSED DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS Glenmark Pharmaceuticals S.A. (CH) 2008-06-18 EP disclosed
WO-2007042906-A1 SUBSTITUTED BENZOFUSED DERIVATIVES AND THEIR USE AS VANILLOID RECEPTOR LIGANDS GLENMARK PHARMACEUTICALS S.A. (US) 2007-04-19 WO disclosed